Placebo effect in children with acute pai

Not Applicable

• Conditions: R52.0; F41.1; Acute pain; Generalized anxiety disorder

• Registration Number: DRKS00029938
• Lead Sponsor: niversitätsklinikum Essen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-08-02
• Study Completion: 2023-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 47

Inclusion Criteria

children between 8 an 14 years old with the medical indication for a peripheral venous cannulae who are able to evaluate pain and anxiety themselves

Exclusion Criteria

(1) not able to evaluate pain/anxiety themselves, (2) younger than 8 years OR older than 14 years old, (3)chronic pain, (4) language barrier, (5)children who received painkillers and/or anxiolytic medication the same day

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
pain (VAS) and anxiety (STAIK) before and after intervention

Secondary Outcome Measures

Name	Time	Method
stress before and after intervention (cortisole level in saliva)